PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma
ANNÉE
2020
AUTEURS
De la Fouchardière C, Hammel P,Launay S,Vienot A, Raimbourg J, Perrier H, Evesque L, Ghiringhelli F, Jary M, Aparicio T, Hociné F, Neuzillet Cindy, Botsen D, Phelip JM, Peytier A, Michel P, Cropet C, Lachaux N, Chabaud S, Dahan L
CONGRÈS/REVUE
ESMO
LIEN PUBLICATIONS ASSOCIÉES